Rita Vanbever

5.2k total citations
87 papers, 4.2k citations indexed

About

Rita Vanbever is a scholar working on Pulmonary and Respiratory Medicine, Pharmaceutical Science and Molecular Biology. According to data from OpenAlex, Rita Vanbever has authored 87 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Pulmonary and Respiratory Medicine, 21 papers in Pharmaceutical Science and 19 papers in Molecular Biology. Recurrent topics in Rita Vanbever's work include Inhalation and Respiratory Drug Delivery (40 papers), Microbial Inactivation Methods (17 papers) and Advancements in Transdermal Drug Delivery (13 papers). Rita Vanbever is often cited by papers focused on Inhalation and Respiratory Drug Delivery (40 papers), Microbial Inactivation Methods (17 papers) and Advancements in Transdermal Drug Delivery (13 papers). Rita Vanbever collaborates with scholars based in Belgium, United States and United Kingdom. Rita Vanbever's co-authors include Véronique Préat, Cynthia Bosquillon, Cristina Loira-Pastoriza, Catherine Lombry, David A. Edwards, Róbert Langer, Cláudia A. Fernandes, Donghao Chen, Bernard Učakar and Uwe Pliquett and has published in prestigious journals such as PLoS ONE, Advanced Functional Materials and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Rita Vanbever

86 papers receiving 4.1k citations

Peers

Countries citing papers authored by Rita Vanbever

Since Specialization

Citations

This map shows the geographic impact of Rita Vanbever's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rita Vanbever with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rita Vanbever more than expected).

Fields of papers citing papers by Rita Vanbever

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rita Vanbever. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rita Vanbever. The network helps show where Rita Vanbever may publish in the future.

Co-authorship network of co-authors of Rita Vanbever

This figure shows the co-authorship network connecting the top 25 collaborators of Rita Vanbever. A scholar is included among the top collaborators of Rita Vanbever based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rita Vanbever. Rita Vanbever is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of protein aggregation on the immunogenicity of a human monoclonal antibody following pulmonary administration in mice 2024 ·International Journal of Pharmaceutics ·(unknown), (unknown), Sandra Gracin, Donatienne Tyteca, Francine Uwambayinema, François Huaux, Mariam Ibrahim, (unknown), Antonio Llinàs, Markus Fridén, Rita Vanbever	0
2	Repurposing DNase I and alginate lyase to degrade the biofilm matrix of dual-species biofilms of Staphylococcus aureus and Pseudomonas aeruginosa grown in artificial sputum medium: In-vitro assessment of their activity in combination with broad-spectrum antibiotics 2024 ·Journal of Cystic Fibrosis ·Zhifen Wang, Rita Vanbever, Joseph H. Lorent, (unknown), Christiane Knoop, Françoise Van Bambeke	6
3	Encapsulation of a CpG oligonucleotide in cationic liposomes enhances its local antitumor activity following pulmonary delivery in a murine model of metastatic lung cancer 2021 ·International Journal of Pharmaceutics ·Cristina Loira-Pastoriza, Kévin Vanvarenberg, Bernard Učakar, (unknown), (unknown), Muriel M. Lemaire, Jean‐Christophe Renauld, Rita Vanbever	27
4	Mind your assays: Misleading cytotoxicity with the WST-1 assay in the presence of manganese 2020 ·PLoS ONE ·(unknown), (unknown), Rita Vanbever, Pascal Jacques, Dominique Lison	42
5	Preclinical evaluation of topically-administered PEGylated Fab’ lung toxicity 2019 ·International Journal of Pharmaceutics X ·(unknown), Natacha Rocks, Harshad P. Patil, (unknown), Jacques Van Snick, Rita Vanbever, Didier Cataldo	6
6	Pulmonary immunization: deposition site is of minor relevance for influenza vaccination but deep lung deposition is crucial for hepatitis B vaccination 2019 ·Acta Pharmaceutica Sinica B ·(unknown), Wouter F. Tonnis, Harshad P. Patil, Anne H. de Boer, Paul Hagedoorn, Rita Vanbever, Henderik W. Frijlink, Wouter L.J. Hinrichs	17
7	Advax augments B and T cell responses upon influenza vaccination via the respiratory tract and enables complete protection of mice against lethal influenza virus challenge 2018 ·Journal of Controlled Release ·(unknown), Harshad P. Patil, Gustavo Bracho, Wouter F. Tonnis, Henderik W. Frijlink, Nikolai Petrovsky, Rita Vanbever, Anke Huckriede, Wouter L.J. Hinrichs	41
8	SPECT-CT Comparison of Lung Deposition using a System combining a Vibrating-mesh Nebulizer with a Valved Holding Chamber and a Conventional Jet Nebulizer: a Randomized Cross-over Study 2016 ·Pharmaceutical Research ·Jonathan Dugernier, Michel Hesse, Rita Vanbever, (unknown), Jean Roeseler, Jean-Bernard Michotte, Pierre‐François Laterre, François Jamar, Grégory Reychler	55
9	PEGylation of paclitaxel largely improves its safety and anti-tumor efficacy following pulmonary delivery in a mouse model of lung carcinoma 2016 ·Journal of Controlled Release ·Tian Luo, Cristina Loira-Pastoriza, Harshad P. Patil, Bernard Učakar, Giulio G. Muccioli, Cynthia Bosquillon, Rita Vanbever	60
10	Therapeutic monoclonal antibodies for respiratory diseases: Current challenges and perspectives, March 31 – April 1, 2016, Tours, France 2016 ·mAbs ·Guillaume Désoubeaux, Janice M. Reichert, Matthew A. Sleeman, Karen L. Reckamp, Bernhard Ryffel, J P Adamczewski, Theresa D. Sweeney, Rita Vanbever, P. Diot, Caroline A. Owen, Clive Page, Stéphanie Lerondel, Alain Le Pape, Nathalie Heuzé‐Vourc'h	39
11	Delivery strategies for sustained drug release in the lungs 2014 ·Advanced Drug Delivery Reviews ·Cristina Loira-Pastoriza, (unknown), Rita Vanbever	301
12	PEGylation of antibody fragments greatly increases their local residence time following delivery to the respiratory tract 2014 ·Journal of Controlled Release ·(unknown), Geneviève Paulissen, Donatienne Tyteca, Hadi Goldansaz, (unknown), (unknown), Catherine Uyttenhove, Jacques Van Snick, Didier Cataldo, Rita Vanbever	74
13	Production, purification and biological characterization of mono-PEGylated anti-IL-17A antibody fragments 2013 ·International Journal of Pharmaceutics ·(unknown), Sam Heywood, Catherine Uyttenhove, (unknown), Jacques Van Snick, Rita Vanbever	15
14	The Particle has Landed—Characterizing the Fate of Inhaled Pharmaceuticals 2010 ·Journal of Aerosol Medicine and Pulmonary Drug Delivery ·John S. Patton, Joseph D. Brain, Lee A. Davies, Jennifer Fiegel, Mark Gumbleton, Kwang‐Jin Kim, Masahiro Sakagami, Rita Vanbever, Carsten Ehrhardt	193
15	Airway Delivery of Low-Dose Miglustat Normalizes Nasal Potential Difference in F508del Cystic Fibrosis Mice 2009 ·American Journal of Respiratory and Critical Care Medicine ·Bob Lubamba, Jean Lebacq, Patrick Lebecque, Rita Vanbever, Anissa Leonard, Pierre Wallemacq, Teresinha Leal	41
16	Preclinical models for pulmonary drug delivery 2009 ·Expert Opinion on Drug Delivery ·Cláudia A. Fernandes, Rita Vanbever	94
17	Mechanistic Studies of Skin Electroporation Using Biophysical Methods 2003 ·Humana Press eBooks ·Mark R. Prausnitz, Uwe Pliquett, Rita Vanbever	4
18	Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance 2001 ·Journal of Controlled Release ·Cynthia Bosquillon, Catherine Lombry, Véronique Préat, Rita Vanbever	252
19	In vivo Noninvasive Evaluation of Hairless Rat Skin after High-Voltage Pulse Exposure 1998 ·Skin Pharmacology and Physiology ·Rita Vanbever, (unknown), (unknown), (unknown), Véronique Préat, Jean‐Paul Marty	38
20	Transdermal permeation of neutral molecules by skin electroporation 1998 ·Journal of Controlled Release ·Rita Vanbever, (unknown), Véronique Préat	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact